HomeBUSINESS
BUSINESS

Interview: Pfizer Japan Looks to Offer High Quality Biosimilars with Go-It-Alone Strategy
(Feb.2.2018)

Pfizer Japan President Akihisa Harada
Akihisa Harada, who was sworn in as president of Pfizer Japan on December 1, recently sat with Jiho to talk about the potential impact of the Japanese government’s upcoming drug pricing reform in April and the company’s strategies surrounding biosimilars, which it eyes as a new target in the country ...
(LOG IN FOR FULL STORY)